NanoGroup S.A. Logo

NanoGroup S.A.

Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.

NNG | WAR

Overview

Corporate Details

ISIN(s):
PLNNGRP00011 (+3 more)
LEI:
259400HXWEAZUWRLY648
Country:
Poland
Address:
Warszawa Rakowiecka 36, 02-532 Warszawa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NanoGroup S.A. is a biotechnology company that develops and commercializes innovative medical solutions based on its unique, patented nanotechnology. The group's research and development work is concentrated on addressing critical medical needs, primarily in the fields of oncology and transplantology. Key projects include the development of nanoformulations for anticancer drugs, a fluid for the storage of organs intended for transplantation, nanoparticles for diagnostics and therapy, and a human blood substitute. The company operates through specialized subsidiaries, such as nanoSanguis and nanoVelos, to advance its distinct technological platforms and bring new medical technologies to market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-27 17:16
Quarterly Report
Raport 2025Q3
Polish 1.1 MB
2025-11-27 17:10
Quarterly Report
Raport 2025Q3
Polish 1.1 MB
2025-11-21 08:55
Regulatory Filings
Strategia 2026-2028
Polish 2.1 MB
2025-11-21 08:55
Management Reports
Strategia Rozwoju NanoGroup S.A. na lata 2026-2028 - Content (PL)
Polish 2.6 KB
2025-11-17 12:46
Share Issue/Capital Change
Inwestycja pośrednia w AUXILIUS PHARMA S.A. - Content (PL)
Polish 4.8 KB
2025-11-10 17:02
Share Issue/Capital Change
Dopuszczenie i wprowadzenie do obrotu giełdowego Akcji Serii K - Content (PL)
Polish 1.4 KB
2025-11-03 19:31
Registration Form
Oświadczenie KDPW
Polish 176.7 KB
2025-11-03 19:31
Share Issue/Capital Change
Rejestracja w Krajowym Depozycie Papierów Wartościowych akcji serii K - Content…
Polish 1.6 KB
2025-10-14 13:02
Registration Form
Statut
Polish 1.5 MB
2025-10-14 13:02
Registration Form
Rejestracja zmian statutu - Content (PL)
Polish 5.1 KB
2025-10-08 16:18
Board/Management Information
Oświadczenie
Polish 156.9 KB
2025-10-08 16:18
Board/Management Information
Oświadczenie
Polish 131.2 KB
2025-10-08 16:18
Board/Management Information
Powołanie osób nadzorujących - członków Rady Nadzorczej drugiej kadencji - Cont…
Polish 1.3 KB
2025-10-08 16:04
Board/Management Information
Rezygnacja Członka Rady Nadzorczej - Content (PL)
Polish 508 bytes
2025-10-08 15:53
Declaration of Voting Results & Voting Rights Announcements
Lista akcjonariuszy
Polish 51.0 KB

Automate Your Workflow. Get a real-time feed of all NanoGroup S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NanoGroup S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NanoGroup S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Inventage Lab Inc. Logo
Develops drug delivery systems using microfluidics for chronic diseases and gene therapies.
South Korea
389470
Inventiva S.A. Logo
Develops oral small molecule therapies for NASH, fibrosis, and rare metabolic disorders.
United States of America
IVA
Invivyd, Inc. Logo
Develops evolution-resistant antibodies to protect against viral diseases like COVID-19 and flu.
United States of America
IVVD
IO Biotech, Inc. Logo
Develops dual-action, off-the-shelf therapeutic cancer vaccines for solid tumors.
United States of America
IOBT
IONIS PHARMACEUTICALS INC Logo
A leader in antisense technology, developing RNA-targeted drugs for neurology and cardiology.
United States of America
IONS
IOVANCE BIOTHERAPEUTICS, INC. Logo
Developing personalized T-cell immunotherapies (TIL) to fight solid tumors and blood cancers.
United States of America
IOVA
Ipsen Logo
Developing innovative medicines for Oncology, Rare Diseases, and Neuroscience.
France
IPN
IRLAB Therapeutics Logo
Developing novel drugs for Parkinson's disease and other neurodegenerative CNS disorders.
Sweden
IRLAB
IRONWOOD PHARMACEUTICALS INC Logo
Develops and commercializes therapies for GI diseases like IBS-C and chronic constipation.
United States of America
IRWD
ISU Abxis Co., Ltd. Logo
Developing antibody-based immunotherapies for oncology and rare diseases.
South Korea
086890

Talk to a Data Expert

Have a question? We'll get back to you promptly.